World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
38421
World Ranking
11149
National Ranking
448

Overview

Daniel Gaudet is affiliated with the University of Montreal in Canada and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work spans various subfields including surgery, cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, cancer research, and molecular biology.

The scientist's research primarily focuses on lipid metabolism and disorders, with significant attention to lipoproteins and cardiovascular health. Other notable topics in their body of work include the interrelation of cancer, lipids, and metabolism; diabetes, cardiovascular risks, and lipoproteins; hyperglycemia and glycemic control in critically ill and hospitalized patients; liver disease diagnosis and treatment; and pharmaceutical economics and policy.

Daniel Gaudet has frequently published in several key medical journals, including:

  • Atherosclerosis
  • Journal of Clinical Lipidology
  • Circulation
  • New England Journal of Medicine
  • Journal of the American College of Cardiology

Collaborations are a notable part of Gaudet's academic career. Frequent co-authors include Diane Brisson, Robert A. Hegele, Christie M. Ballantyne, Frederick J. Raal, and Robert S. Rosenson, reflecting interdisciplinary cooperation among researchers in cardiovascular and metabolic disease.

Noteworthy recent publications associated with Daniel Gaudet include:

  • Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society, 2021, European Heart Journal
  • Evinacumab for Homozygous Familial Hypercholesterolemia, 2020, New England Journal of Medicine
  • Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease, 2022, New England Journal of Medicine
  • Evinacumab in Patients with Refractory Hypercholesterolemia, 2020, New England Journal of Medicine
  • Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial, 2021, The Lancet Respiratory Medicine

Best Publications

  • The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

    David Altshuler;Joel N. Hirschhorn;Joel N. Hirschhorn;Joel N. Hirschhorn;Mia Klannemark;Cecilia M. Lindgren;Cecilia M. Lindgren

  • Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

    John J.P. Kastelein;Fatima Akdim;Erik S.G. Stroes;Aeilko H. Zwinderman

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

    Isabelle Lemieux;Agnès Pascot;Charles Couillard;Benoı̂t Lamarche

  • Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

    Frederick J Raal;Raul D Santos;Dirk J Blom;A David Marais

  • Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

    John D. Rioux;Mark J. Daly;Mark S. Silverberg;Kerstin Lindblad

  • PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial

    Frederick J Raal;Evan A Stein;Robert Dufour;Traci Turner

  • Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

    Evan A Stein;Dan Gipe;Jean Bergeron;Daniel Gaudet

  • Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.

    Marina Cuchel;Emma A. Meagher;Hendrik Du Toit Theron;Dirk J. Blom;Dirk J. Blom

  • Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

    Alexandra-Chloé Villani;Mathieu Lemire;Geneviève Fortin;Edouard Louis

  • Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

    Claude Gagné;Daniel Gaudet;Eric Bruckert

  • Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

    Daniel Gaudet;Veronica J. Alexander;Brenda F. Baker;Diane Brisson

  • Evinacumab for Homozygous Familial Hypercholesterolemia

    Frederick J. Raal;Robert S. Rosenson;Laurens F. Reeskamp;G. Kees Hovingh

  • Targeting APOC3 in the Familial Chylomicronemia Syndrome

    Daniel Gaudet;Diane Brisson;Karine Tremblay;Veronica J. Alexander

  • Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

    Henry N Ginsberg;Chris J Packard;M John Chapman;Jan Borén

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome

    Joseph L Witztum;Daniel Gaudet;Steven D Freedman;Veronica J Alexander

  • Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial

    D Gaudet;J Méthot;S Déry;D Brisson

  • Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.

    Ulrich Laufs;Maciej Banach;G. B. John Mancini;Daniel Gaudet

  • Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia Results of a Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety as Add-On Therapy in Patients With Coronary Artery Disease

    Evan A. Stein;Robert Dufour;Claude Gagne;Daniel Gaudet

  • Haplotype Structure and Genotype-Phenotype Correlations of the Sulfonylurea Receptor and the Islet ATP-Sensitive Potassium Channel Gene Region

    Jose C. Florez;Noël Burtt;Paul I.W. de Bakker;Peter Almgren

Frequent Co-Authors

Tomáš Paus
Tomáš Paus University of Toronto
Thomas J. Hudson
Thomas J. Hudson Ontario Institute for Cancer Research
Jean-Pierre Després
Jean-Pierre Després Université Laval
Michal Abrahamowicz
Michal Abrahamowicz McGill University
Gabriel Leonard
Gabriel Leonard Montreal Neurological Institute and Hospital
Robert A. Hegele
Robert A. Hegele University of Western Ontario
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
Pavel Hamet
Pavel Hamet University of Montreal
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Joel N. Hirschhorn
Joel N. Hirschhorn Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open alternative career pathways in the health sector. For students who want to work in healthcare but don't wish to become physicians, nursing is a popular option. Many programs now cater to diverse backgrounds. For example, online direct entry MSN programs for non-nurses provide a fast track for individuals holding a non-nursing bachelor’s degree to transition into advanced nursing roles.

Admission standards also vary. Some schools offer direct entry nursing programs with less competitive requirements, making them more accessible for applicants. Additionally, those interested in supporting healthcare operations rather than providing hands-on care can consider studying at one of the best medical billing and coding schools online, which often offer financial aid.

For applicants concerned about admission exams, there are even nursing school that does not require teas test, simplifying the process further. These diverse online routes provide flexible, achievable alternatives for building a healthcare career in the USA.

Best Scientists Citing Daniel Gaudet

Trending Scientists

Recently Published Articles